Slawson Matthew H, Chen Meng, Moody David, Comer Sandra D, Nuwayser Elie S, Fang Wenfang B, Foltz Rodger L
Center for Human Toxicology, Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah 84112, USA.
J Anal Toxicol. 2007 Oct;31(8):453-61. doi: 10.1093/jat/31.8.453.
To improve the analysis of naltrexone and its primary metabolite 6beta-naltrexol, a sensitive and specific method for the analysis of subnanogram-per-milliliter concentrations of these analytes in human, rat, and rabbit plasma was developed utilizing liquid chromatography (LC) coupled to electrospray ionization (ESI) tandem mass spectrometry (MS-MS). Plasma samples were extracted utilizing a liquid-liquid extraction technique. Chromatographic separation was achieved using an isocratic solvent system consisting of dilute formic acid and methanol pumped through an ODS-AQ HPLC column. ESI-MS-MS was in the positive ion mode followed by collision-induced dissociation of the protonated molecular ions for naltrexone, 6beta-naltrexol, and their deuterated analogues. This method was validated using Good Laboratory Practice approved methods and was compared to an existing gas chromatography (GC)-MS method by analyzing plasma samples collected from a clinical study. Specificity determined from comparing blank plasma fortified with internal standard to samples fortified with internal standard and analyte at the lower limit of quantitation (LLOQ) from six different human, rat, and rabbit sources demonstrated sufficient signal-to-noise to set the LLOQ at 0.1 ng/mL. This assay has a quantitative range of 0.1-100 ng/mL. The inter- (human only) and intra-assay precision and accuracy in plasma varied by less than 13, 11, and 16% at the LLOQ for both analytes and by less than 10, 10, and 9% at higher concentrations for human, rat, and rabbit plasma, respectively. No loss of analyte was observed after 24 h of room temperature storage in human, rat, and rabbit plasma or three cycles of freezing and thawing of human plasma prior to extraction. Human samples that had been extracted were stable for at least five days when stored frozen at -20 degrees C or for at least two days when stored at room temperature on an autosampler. The GC-MS and LC-MS-MS methods correlated in the measured plasma concentrations of both naltrexone and 6beta-naltrexol. This method has been validated and subsequently used in the determination of the pharmacokinetics of Depotrex in rabbits. In rabbits, the parent compound shows dose-dependent pharmacokinetics as seen in humans, but rabbits have much lower unconjugated metabolite, 6beta-naltrexol, than that seen in humans.
为改进纳曲酮及其主要代谢物6β-纳曲醇的分析方法,开发了一种灵敏且特异的方法,用于测定人、大鼠和兔血浆中亚纳克/毫升浓度的这些分析物,该方法采用液相色谱(LC)与电喷雾电离(ESI)串联质谱(MS-MS)联用。血浆样品采用液-液萃取技术进行萃取。使用由稀甲酸和甲醇组成的等度溶剂系统,通过ODS-AQ高效液相色谱柱实现色谱分离。ESI-MS-MS采用正离子模式,随后对纳曲酮、6β-纳曲醇及其氘代类似物的质子化分子离子进行碰撞诱导解离。该方法采用经良好实验室规范认可的方法进行验证,并通过分析来自一项临床研究收集的血浆样品,与现有的气相色谱(GC)-MS方法进行比较。通过比较用内标强化的空白血浆与在六个不同人、大鼠和兔来源的定量下限(LLOQ)处用内标和分析物强化的样品来确定特异性,结果表明有足够的信噪比将LLOQ设定为0.1 ng/mL。该测定法的定量范围为0.1-100 ng/mL。两种分析物在LLOQ时,血浆中的批间(仅人)和批内精密度及准确度在人、大鼠和兔血浆中分别变化小于13%、11%和16%,在较高浓度时分别变化小于10%、10%和9%。在人血浆、大鼠血浆和兔血浆中,室温储存24小时后或在萃取前对人血浆进行三个冻融循环后,均未观察到分析物损失。萃取后的人样品在-20℃冷冻储存时至少稳定五天,或在自动进样器上室温储存时至少稳定两天。GC-MS和LC-MS-MS方法在纳曲酮和6β-纳曲醇的血浆测定浓度方面具有相关性。该方法已得到验证,并随后用于测定兔体内长效纳曲酮的药代动力学。在兔体内,母体化合物表现出与人相似的剂量依赖性药代动力学,但兔体内未结合代谢物6β-纳曲醇的含量远低于人。